Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

16
Number of overlapping holdings
32.7%
% of FTXH's 51 holdings also in XPH
43.2%
% of XPH's 40 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in XPH |
Overlap | |
---|---|---|---|---|
MERCK & CO. INC. | 7.2% | 4.2% | 4.2% | |
JOHNSON & JOHNSON | 7.3% | 4.0% | 4.0% | |
BRISTOL-MYERS SQUIBB CO | 7.0% | 3.9% | 3.9% | |
ELI LILLY & CO | 3.8% | 5.6% | 3.8% | |
PFIZER INC | 7.0% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to XPH
ABBVIE INC | 7.5% | |
AMGEN INC | 3.7% | |
CARDINAL HEALTH INC | 3.7% | |
VERTEX PHARMACEUTICALS INC | 3.6% | |
REGENERON PHARMACEUTICALS | 3.6% | |
GILEAD SCIENCES INC | 3.6% | |
BIOGEN IDEC INC | 3.5% | |
PFIZER INC | 3.2% | |
JOHNSON & JOHNSON | 3.2% | |
BRISTOL-MYERS SQUIBB CO | 3.0% |
FTXH Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% | |
ELANCO ANIMAL HEALTH, INC. | -5.2% | |
CATALENT INC | -4.6% | |
AXSOME THERAPEUTICS, INC. | -3.9% | |
ROYALTY PHARMA PLC CLASS A | -3.7% | |
INTRA-CELLULAR THERAPIES INC | -3.1% | |
VENTYX BIOSCIENCES, INC. | -3.0% | |
PERRIGO CO | -2.7% | |
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.3% | |
CORCEPT THERAPEUTICS INC | -2.2% |